(Q33909727)

29 July 2017

1 reference

title

Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome (English)

1 reference

ovarian hyperstimulation syndrome

29 July 2017

1 reference

M Aboulghar

1

1 reference

29 July 2017

J H Evers

series ordinal

2

1 reference

29 July 2017

H Al-Inany

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2002

0 references

published in

1 reference

29 July 2017

CD001302

1 reference

29 July 2017

2

1 reference

The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial.

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in-vitro fertilization programme: a prospective randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Human albumin administration in critically ill patients: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

ABC of transfusion. Human albumin solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Thromboembolic disease associated with ovarian stimulation and assisted conception techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Use of intramuscular progesterone versus intravenous albumin for the prevention of ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

Risk factors and prognostic variables in the ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001302

10.1002/14651858.CD001302

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference